Protagonist Therapeutics

BalançosProtagonist Therapeutics

PTGX

A Protagonist Therapeutics Inc é uma empresa biofarmacêutica de estágio clínico que permite a descoberta e o desenvolvimento de novos medicamentos à base de peptídeos restritos para atender às necessidades médicas. Seus dutos incluem Rusfertide (PTG-300) e JNJ-2113.

Tabela de balanços completa e atualizada com os principais indicadores financeiros: Lucro Líquido, Receita, EBTIDA, Margem, ROE, Dividendos

Ano
12/2016
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2017
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2018
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2019
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2020
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2021
27
-125
-123
P
P
300
P
-327
-
-124
-1
130
-125
-0
0
-
-
12/2022
27
-130
-123
P
P
216
P
-237
-
-132
-1
19
-133
-0
0
-
-
12/2023
60
-93
-12
P
P
337
P
-342
-
-100
-1
170
-100
-1
0
-
-
12/2024
434
254
012
63%
4.2
675
41%
-419
-
147
-1
26
145
-1
0
-
-
12/2025
46
-157
-123
P
P
615
P
-567
-
12
-2
23
10
-0
0
-
-